Inventor · disambiguated record
Cynthia W. Tuthill
Also filed as: TUTHILL CYNTHIA · TUTHILL CYNTHIA W
8 granted patents·24 pending applications·20 citations·filing 2002–2023
81Inventor score
Files withSCICLONE PHARMACEUTICALS INC22TUTHILL CYNTHIA W4SCICLONE PHARMACEUTICALS INT LTD2MOSSEL ERIC C1RUDOLPH ALFRED R1
Top patents by PatentIndex Score
32 records- 0182US9724395B2Treatment of cancer with immune stimulatorsSCICLONE PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·4 cites·25 claims
- 0282US2024091314A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0379US7297676B2Thymosin alpha 1 peptide/polymer conjugatesSCICLONE PHARMACEUTICALS INC·Filed 2002·Granted Nov 20, 2007·11 cites·31 claims
- 0475US11571465B2Treatment of cancer with alpha thymosin peptide and PD-1 inhibitorsSCICLONE PHARMACEUTICALS INT LTD·Filed 2020·Granted Feb 7, 2023·1 cites·31 claims
- 0566US2015024994A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0664US8163702B2Treatment of melanomaTUTHILL CYNTHIA W·Filed 2007·Granted Apr 24, 2012·1 cites·21 claims
- 0763US7906486B2Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosaSCICLONE PHARMACEUTICALS INC·Filed 2008·Granted Mar 15, 2011·1 cites·13 claims
- 0862US2021106656A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
- 0959US7897567B2Methods of protecting against radiation damage using alpha thymosinSCICLONE PHARMACEUTICALS INC·Filed 2003·Granted Mar 1, 2011·1 cites·21 claims
- 1059US2008300166A1Treatment of Melanoma with Alpha Thymosin PeptidesSCICLONE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1158US8193152B2Treatment or prevention of hemorrhagic viral infections with immunomodulator compoundsMOSSEL ERIC C·Filed 2005·Granted Jun 5, 2012·1 cites·10 claims
- 1258US2018161399A1Treatment of cancer with immune stimulatorsSCICLONE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1358US2018236036A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1458US2013296223A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1554US2010016211A1Treatment of Melanoma With Alpha Thymosin PeptidesSCICLONE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1653US2011189305A1Treatment of lung cancerTUTHILL CYNTHIA W·Filed 2008·Application pending·0 cites
- 1752US2008152668A1Thymosin Alpha 1 Peptide/Polymer ConjugatesSCICLONE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1851US2010267637A1Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitorSCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1950US2009074815A1Immunomodulator Compounds as Vaccine EnhancersSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2049US2010221274A1Method of administering a thymosin alpha 1 peptideSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2146US2006052404A1Pharmaceutical formulations comprising substituted xanthine compoundsRUDOLPH ALFRED R·Filed 2002·Application pending·0 cites
- 2245US2011200558A1Treatment or Prevention of Hepatitis C with Immunomodulator CompoundsSCICLONE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2344US2005049191A1Method of administering a thymosin alpha 1 peptideSICCLONE PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2443US2007036744A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2541US2007087974A1Treatment or prevention of respiratory viral infections with immunomodulator compoundsSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2640US2010317583A1Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)SCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2740US2010330093A1Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)SCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2839US8716012B2Alpha thymosin peptides as vaccine enhancersTUTHILL CYNTHIA W·Filed 2010·Granted May 6, 2014·0 cites·33 claims
- 2939US2014213506A1Thymosin alpha peptide for preventing, reducing the severity of, and treating infectionTUTHILL CYNTHIA W·Filed 2012·Application pending·0 cites
- 3035US2011117211A1Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of MucosaSCICLONE PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3134US2010197595A1Treatment of melanoma with alpha thymosin peptidesSCICLONE PHARMACETICALS INC·Filed 2010·Application pending·0 cites
- 3233US2010311656A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cynthia W. Tuthill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →